RxDoctor Payments Data
★ My doctorsLook up a doctor →

Kenneth Ratzan

Infectious Disease · Miami Beach, FLNPI 1366415572

Payments from drug & device makers

$3,121in general payments, 2019–2025

Across 161 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Gilead$413
  • Viiv Healthcare Company$332
  • Johnson & Johnson$288
  • Merck$211
  • Tetraphase Pharmaceuticals, Inc.$118
  • plus $333 from 6 others

What the payments were for

  • Food & beverage$3,121100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)65$1,425
Gilead24$413
Viiv Healthcare Company20$332
Johnson & Johnson17$288
Merck13$211
Tetraphase Pharmaceuticals, Inc.6$118
Melinta Therapeutics, LLC3$86
Theratechnologies Inc.4$75
Insmed, Inc.3$74
EMD Serono, Inc.2$39
Pfizer2$32
Astellas Pharma US Inc2$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,121 in reported general payments places this provider in the 65th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida →

Other infectious disease in Miami Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →